Company: PBH
Filing Date: 2025-06-27
Form Type: DEF 14A
Source: 0001295947-25-000021
Chunk: 28

Company: Prestige Consumer Healthcare Inc.
Filing Date: 2025-06-27
Form: DEF 14A
Chunk 28
---
 grant date fair value of the stock awards granted in 2025, determined in accordance with FASB ASC Topic 718. On August 5, 2024, Mr. Kelly received 555 restricted stock units, representing $37,500 divided by $67.58 (the closing stock price of our common stock on the NYSE on August 5, 2024). On August 6, 2024, each of Mses. Clark, Hopkins and Zier and Messrs. Byom, D’Arecca and Kelly received 2,202 restricted stock unit s, representing $150,000 divided by $68.13 (the closing price of our common stock on the NYSE on August 6, 2024). The restricted stock units, which entitle the grantee to receive one share of common stock for each restricted stock unit, vest one year from the date of the grant and will be settled, at each recipient’s prior election, either upon vesting or upon the earliest to occur of such director’s death, disability or the cessation of board service for any reason other than death or disability. As of March 31, 2025, Mses. Clark, Hopkins and Zier and Messrs. Byom, D’Arecca and Kelly held 11,436, 28,029, 14,439, 52,500, 4,497, and 2,757 restricted stock units under the Company’s equity compensation plans, respectively. As of March 31, 2025, none of our directors held any stock options.

| Prestige Consumer Healthcare Inc. | 2025 Proxy Statement |     | 37 |

OUR EXECUTIVE OFFICERS

Our executive officers are as follows:

|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |     |         | Ronald M. LombardiChair of the Board, President and Chief Executive Officer |
|                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |     | Age: 61 |                                                                             |
| Career Highlights:Ronald M. Lombardi was elected Chair of the Board in May 2017 and has served as a director and as President and ChiefExecutive Officer of the Company since June 2015. He served as Chief Financial Officer of the Company from December 2010until November 2015. Prior to joining the Company, from October 2010 to December 2010, Mr. Lombardi was employed byMedtech Group Holdings, a components and contract